LBX Pharmacy Chain Joint Stock CompanySSE: 603883

Announcement on Convening the Q3 2025 Performance Briefing

Nov 25, 2025 · Issued by LBX Pharmacy Chain Joint Stock Company via Shanghai Stock Exchange

Filed with SSE · Nov 25, 2025

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2025-performance-briefing-918

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

LBX Pharmacy Chain Joint Stock Company on 6ix

Earlier from LBX Pharmacy Chain Joint Stock

Notice on Convening the 1st Extraordinary General Meeting in 2025Nov 12, 2025
Announcement on Implementation of Dividend Distribution for Q3Nov 6, 2025
Announcement on Revision to Partial Corporate Internal Governance SystemsOct 29, 2025
Announcement on Implementing Repurchase and Cancellation of Equity Incentive Restricted StocksOct 21, 2025
Announcement on Resignation of Senior Management MembersOct 11, 2025

Later from LBX Pharmacy Chain Joint Stock

Announcement on Resignation of Director and Election of Employee DirectorNov 29, 2025
Announcement on Resolutions of the 12th Meeting of the 5th Board of DirectorsDec 2, 2025
Announcement on Outline of the Q3 2025 Performance Briefing (November 2025)Dec 4, 2025
Announcement on Return of Raised Funds Temporarily Used to Supplement Current CapitalDec 26, 2025
Announcement on Progress in Providing Guarantees for Wholly-owned SubsidiariesJan 21

All LBX Pharmacy Chain Joint Stock news releases

Follow LBX Pharmacy Chain Joint Stock into a list and get an email when it puts out news.

Follow LBX Pharmacy Chain Joint Stock